Indegene Limited raises ₹ 548.77 crore from 36 anchor investors at the upper price band of ₹452 per equity share - Indegene Limited raises ₹548.77 crore from 36 anchor investors at the upper price band of ₹452 per equity share - CtrlS Noida Datacenter Turns to Solar for 60% of its Power Requirement, Aims to reduce 94,640 tonnes of CO2 emissions through this move - TBO TEK LIMITED ANNOUNCED IT'S INITIAL PUBLIC OFFERING (IPO) TO OPENS ON 08th May, 2024 Sets Price Band fixed at ₹ 875 to ₹ 920 per equity share of face value of ₹ 1 each - Afternoon Voice Hosts 16th Newsmakers Achievers Award 2024, Recognising Outstanding Contributions Across Various Fields - AADHAR HOUSING FINANCE LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES OPENS ON MAY 8, 2024 Sets Price Band fixed at ₹ 300 to ₹ 315 per equity share of face value of ₹ 10 each - Sankalp Art Fest Presents An Art Exhibition will be held @ Namah Royal Banquet Hall at Borivali (W) in Mumbai - Collaborates with the Akshaya Patra Foundation for Sustainable Growth in India - Kokilaben Hospital launches Arthrex Modular Glenoid System with VIP for Enhanced Shoulder Replacement for the First Time in India - उत्तर मुंबई मतदार संघातील पीयूष गोयल यांचा उमेदवारी अर्ज दाखल, जल्लोषात समर्थन देत भाजप - महायुती कार्यकर्त्यांचे जोरदार शक्तीप्रदर्शन

Unaudited Standalone and Consolidated Financial Results For the quarter ended December 31, 2020



Mumbai, 13th February 2021 (GNI): Unaudited Standalone and Consolidated Financial Results
For the quarter ended December 31, 2020
INR Mn Particulars
Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20
(Consolidated) (Consolidated) (Standalone) (Standalone)
Revenue 14,283 13,000 5,225 3,524
EBIDTA 1,225 -819 382 -943
PAT -1,228 -2,838 -752 -1,832

INR Mn Particulars
9M FY21 9M FY20 9M FY21 9M FY20
(Consolidated) (Consolidated) (Standalone) (Standalone)
Revenue 40,842 45,976 13,882 15,763
EBIDTA 2,737 2,680 526 685
PAT -4,518 -3,953 -2,851 -2801

Jain Irrigation Systems Limited, the largest Micro Irrigation Systems Company in the country and second largest globally, has announced unaudited standalone and consolidated results for the third quarter of FY 2021.
Highlights of Q3 and 9M FY 21:
 Consolidated Revenue was at INR 14,283 Mn in Q3 FY21,Standalone revenue was at 5,225 Mn
 Consolidated EBIDTA was at INR 1,225 Mn in Q3 FY21, Standalone EBITDA was at INR 382 Mn
 Consolidated PAT was at INR (1,228) Mn in Q3 FY21, Standalone PAT was at INR (752) Mn
 Consolidated Revenue was at INR 40,842 Mn in 9M FY21,Standalone revenue was at 13,882 Mn
 Consolidated EBIDTA was at INR 2,737 Mn in 9M FY21, Standalone EBITDA was at INR 526 Mn
 Consolidated PAT was at INR (4,518) Mn in 9M FY21, Standalone PAT was at INR (2,851) Mn
 Global order book now stands at over INR 42 billion Vice Chairman and Managing Director of the Company, Mr Anil Jain said:
“We are pleased to present the Q3 financial result of the Company. We entered the Q3 period in October with uncertainty of the covid all around and skepticism in mind, but with the hope that scenario can only be better. With this belief, our teams in rural and semi-urban areas have catered admirably to the agriculture sector. We are an agri-inputs Company with our range of products, services and advisory and feel proud to have contributed to the agri sector which has shown good growth amongst the GDP constituents in last three quarters. This is well reflected in the better financials of the Company in the quarter.
On the standalone Company, we are pleased with the run rate achieved and the ebitda has turned positive. The debt resolution has progressed well and we are pleased to state that we are close to implementation in coming weeks. Hereafter, we are confident of increasing the capacity utilization and increasing the product range in the near times to come. The overseas subsidiaries’ performance continues to be stable with steady growth, despite challenging covid times. Of our various locations, certain geographies like Israel are ahead in vaccination and this is lending support to the business. In India, we are gradually increasing the dealer network and spreading outreach into newer districts.
While we take all these steps, we are maintaining focus on improving further working capital efficiencies and controlling costs and thereby improving margins.
We continue to engage intensively with the lenders on the debt resolution and sincerely thank them for their continued support. We are hoping to perform better in Q4, which is a busy period for our operations. We are seeking and are thankful to the employees, customers, vendors and advisors for their unwavering support and understanding of the times. “
About Jain Irrigation: Our Company, Jain Irrigation Systems Limited (JISL) with it’s motto ‘Small Ideas, Big Revolutions’ with more than 10,500+ associates worldwide and revenue of ~USD 1.2 Bn, is an Indian multinational company with manufacturing plants in 30
locations across the globe. JISL, its subsidiaries and associates are engaged in manufacturing of Micro Irrigation Systems, PVC Pipes, HDPE Pipes, Plastic Sheets, Agro Processed Products, Renewable Energy Solutions, Tissue Culture Plants, Financial Services and other agricultural inputs since more than 34 years. It has pioneered a silent Productivity Revolution with modern irrigation systems and innovative technologies in order to save precious water and has helped to get significant increase in crop yields, especially for millions of the small farmers. It has also ushered in new concept of large scale Integrated Irrigation Projects (IIP). ‘More Crop Per Drop™’ is the company’s approach to water security and food security. All the products & services of JISL help create sustainable future while fulfilling its vision ‘Leave this world better than you found it’. JISL is listed in NSE-Mumbai at JISLJALEQS and in BSE at code 500219. Please visit us at www.jains.com

Be the first to comment on "Unaudited Standalone and Consolidated Financial Results For the quarter ended December 31, 2020"

Leave a comment

Your email address will not be published.


*